Peak6 Investments LLC Aurinia Pharmaceuticals Inc. Transaction History

Peak6 Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$7.13 - $9.49 $51,385 - $68,394	7,207 Added 11.08%	72,239 $649,000
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $17,521 - $27,668	2,255 Added 3.59%	65,032 $505,000
Q2 2023 Aug 11, 2023	BUY	$8.96 - $11.69 $35 - $46	4 Added 0.01%	62,777 $607,000
Q1 2023 May 12, 2023	BUY	$5.94 - $11.27 $33,275 - $63,134	5,602 Added 9.8%	62,773 $687,000
Q4 2022 Feb 10, 2023	BUY	$4.11 - $8.14 $135,650 - $268,660	33,005 Added 136.58%	57,171 $247,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $39 - $74	6 Added 0.02%	24,166 $182,000
Q2 2022 Aug 12, 2022	SELL	$8.95 - $12.8 $35 - $51	-4 Reduced 0.02%	24,160 $243,000
Q1 2022 May 13, 2022	BUY	$10.05 - $22.48 $152,649 - $341,448	15,189 Added 169.24%	24,164 $299,000
Q4 2021 Feb 11, 2022	BUY	$17.78 - $33.08 $159,575 - $296,893	8,975 New	8,975 $205,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.